Definitive chemoradiotherapy (CRT) for anal cancer spares patients the morbidity of a
colostomy surgery and optimizes cancer outcomes. CRT, however, has introduced a unique …

Anal cancer is uncommon but increasing in incidence despite increased availability of
vaccines and screening approaches. 1 There are many types of anal cancer, with 5% being …

Purpose Definitive radiation therapy with concurrent chemotherapy is curative for
nonmetastatic squamous cell carcinoma of the anus (SCCA). However, the true effect of …

Purpose Patients with localized squamous cell carcinoma of the anus (SCCA) who
experience treatment toxicity or recurrences have few therapeutic options. Investigation into …

Background: To research the impact of a Chinese traditional medicine (Citrus aurantium L.)
on gastric cancer proliferation and mice gastrointestinal motility. Materials and Methods: The …

Introduction Human Papillomavirus (HPV) is the primary risk factor for the development of
anal intraepithelial neoplasia (AIN) and is a leading risk factor for anogenital squamous cell …

Purpose Patient-reported outcome (PRO) and National Cancer Institute-Common
Terminology Criteria for Adverse Events (NCI-CTCAE) data for patients with squamous cell …

Introduction: Anal cancer is a rare malignancy, but incidence rates are rising. Primary
chemoradiation is the standard of care for early disease with surgery reserved for salvage …

• Chemoradiation using the Nigro protocol remains the mainstay of treatment for locally
advanced anal cancer with 70% to 80% of patients having durable locoregional control.• …

IMPORTANCE Patients with localized squamous cell carcinoma of the anus (SCCA) who
experience treatment toxicity or recurrences have few therapeutic options. Investigation into …